Consultation on 2021/22 National Tariff Payment System is now open in England

08

Apr 2021

On March 22, 2021, NHS England and NHS Improvement released 2021/22 National Tariff Payment System (NTPS) consultation documents and launched an online feedback survey that closes on April 30, 2021.

The principal proposal for the 2021/22 NTPS is to Introduce a new "Aligned Payment and Incentive" (API) approach for almost all services in the tariff scope. During the engagement on proposals for 2021/22, the payment approach was described as blended payment. However, there was some confusion about how the proposals related to the blended payments introduced in previous years. The NHS wants to be clear that the current proposals (API) are significantly different from the last blended payment model.

API includes a fixed element of payment, a variable element (relating to the volume of elective inpatient, day case, and outpatient procedure activity), and a quality-related element (Best Practice Tariffs and Commissioning for Quality and Innovation, CQUIN). CQUIN funding is, therefore, transferred into the NTPS.

Another significant amendment is that national prices are now limited to unbundled diagnostic imaging services (i.e., diagnostic imaging not part of an inpatient spell). All other prices are calculated and published as unit prices.

A target date for the NTPS to come into effect is not defined yet. The NTPS could be published later in 2021/22 when it is decided to end the measures related to COVID-19.

See consultation documents, annexes, supporting documents here, online survey here

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more